JNJ-17203212 is a selective, highly effective, competitive TRPV1 antagonist. JNJ-17203212 was developed for research on pain management, such as migraines.
Molecular Weight:
419.32
Purity:
>99%
CAS Number:
[821768-06-3]
Formula:
C17H15F6N5O
Target:
TRP Channel
* VAT and and shipping costs not included. Errors and price changes excepted